Traws Pharma, Inc.（TRAW）内部人交易：高管与董事近期交易
过去 18 个月，共有 12 位内部人为 Traws Pharma, Inc.（TRAW）报告了 12 笔 Form 4 交易（最近一笔 2026-04-28）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-04-28 | ORBIMED ADVISORS LLC | 10% 以上股东 | 买入 | 597,729 | $998,207 |
| 2026-04-28 | OrbiMed Capital GP VIII LLC | 10% 以上股东 | 买入 | 597,729 | $998,207 |
| 2026-04-08 | Parker Charles Nolan | Chief Financial Officer | 买入 | 15,393 | $0 |
| 2025-12-16 | Dukes Iain D. | Chief Executive Officer | 买入 | 36,943 | $0 |
| 2025-12-16 | Shoemaker Mary Teresa | 董事 | 买入 | 6,157 | $0 |
| 2025-12-16 | CAUTREELS WERNER | 董事 | 买入 | 4,874 | $0 |
| 2025-12-16 | Clarke Trafford | 董事 | 买入 | 6,157 | $0 |
| 2025-12-16 | Redfield Robert | Chief Medical Officer | 买入 | 16,419 | $0 |
| 2025-12-16 | Pauza Charles David | Chief Science Officer Virology | 买入 | 18,471 | $0 |
| 2025-12-16 | STOVER JACK E | 董事 | 买入 | 6,157 | $0 |
| 2025-12-16 | Leaman John Harold | 董事 | 买入 | 4,058 | $0 |
| 2025-12-16 | Savchuk Nikolay | Chief Operating Officer | 买入 | 16,419 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-04-28